Bilibili ( ($BILI) ) has issued an announcement. On December 11, 2025, Bilibili Inc. announced changes in its issued shares, primarily through the ...
Pfizer Inc. today announced detailed results from the Phase 3 HER2CLIMB-05 trial of the tyrosine kinase inhibitor TUKYSA® (tucatinib) as part of an investigational first-line maintenance treatment ...
Luxury Columnist on MSN
The future of preventative healthcare: Superpower biomarker testing
We tried out one of the most advanced baseline diagnostic panels available – here’s what we discovered about our health […] ...
Legendary actor Amitabh Bachchan lives with just 25% liver function, a testament to the organ's remarkable regeneration.
Eli Lilly and Company (NYSE: LLY) today announced results from the Phase 3 BRUIN CLL-313 clinical trial of Jaypirca ...
Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today positive topline results in its 13-week Phase II study evaluating ASC30, an oral small molecule GLP-1 receptor (GLP-1R) agonist for the ...
Here's a look at the upcoming WWE schedule: Dec. 12, 2025: SmackDown, Mohegan Arena at Casey Plaza, Wilkes-Barre, PA Dec. 13, 2025: Saturday Night's Main Event ...
KOMZIFTI (ziftomenib), the first and only once-daily oral menin inhibitor for adult patients with R/R AML with a susceptible NPM1 mutation who have no satisfactory alternative treatment options, has ...
Clear dose-response observed, with a robust and clinically meaningful fetal hemoglobin (HbF) induction at the Week 6 timepoint (n=12): mean ...
11Alive+ features the latest breaking news and weather, plus daily talk shows, coverage of your favorite sports teams from Locked On, and exclusive content - all completely free. Weather Impact 24/7 ...
Key points A 62-year-old man with hypertension and chronic renal disease presented to an emergency department with abdominal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback